Search clinical trials for: EOC202
Total 41 results
-
EmmecellActive, not recruitingEndothelial Dysfunction | Corneal Edema | Fuchs Dystrophy | Corneal Endothelial Dystrophy | Bullous Keratopathy | Pseudophakic Bullous Keratopathy | Corneal Endothelial Dysfunction | Fuchs Endothelial Corneal Dystrophy | Moderate Corneal Endothelial DecompensationUnited States
-
Shanghai Yiteng Jingang Bio-pharmaceutical Technology...Recruiting
-
Asociación para Evitar la Ceguera en MéxicoEmmecellRecruitingEndothelial Dysfunction | Corneal Edema | Fuchs' Endothelial Dystrophy | Fuchs Dystrophy | Corneal Endothelial Dystrophy | Bullous Keratopathy | Pseudophakic Bullous Keratopathy | Corneal Edema PseudophakicMexico
-
A2 Healthcare Taiwan CorporationGoldenMed BioTechnologyWithdrawnHepatocellular Carcinoma | Liver Fibrosis | HEPATITIS B CHRONICTaiwan
-
Taizhou EOC Pharma Co., Ltd.CompletedSolid Tumor, AdultChina
-
Ocumension Therapeutics (Shanghai) Co., LtdCompleted
-
Asociación para Evitar la Ceguera en MéxicoEmmecellRecruiting
-
Taizhou EOC Pharma Co., Ltd.Not yet recruiting
-
EndocyteCompleted
-
HI-BioCompletedTrial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) (M-PLACE)Glomerulonephritis, Membranous | antiPLA2R PositiveSpain, Belgium, Australia, Italy, United States, Korea, Republic of, France, Netherlands, Poland
-
HI-BioCompletedImmunoglobulin A (IgA) NephropathyUnited Kingdom, Germany, Spain, Serbia, Taiwan, Australia, Japan, Korea, Republic of, Belgium, United States, Bulgaria, Czechia, Georgia, Malaysia, Philippines, Ukraine
-
Fujifilm Medical Systems USA, Inc.Completed
-
Mario Negri Institute for Pharmacological ResearchMorphoSys AGActive, not recruiting
-
HI-BioCompletedGlomerulonephritis | Membranous Nephropathy | antiPLA2R PositiveTaiwan, Korea, Republic of, Greece, Germany, United Kingdom, Georgia, Russian Federation
-
Virginia KrausEli Lilly and Company; EndocyteCompleted
-
Farsad EskandaryCharite University, Berlin, Germany; University of Alberta; HI-BioCompleted
-
Advanced Cooling Therapy, Inc., d/b/a Attune MedicalThomas Jefferson UniversityTerminatedSurgery | Hypothermia | Hypothermia Following AnesthesiaUnited States
-
University Hospital, BrestCyclacel Pharmaceuticals, Inc.; ManRos TherapeuticsTerminated
-
Shlomo Melmed, MDNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Terminated
-
LUTRONIC CorporationUnknown
-
Cyclacel Pharmaceuticals, Inc.TerminatedNon-small Cell Lung CancerUnited States
-
Cyclacel Pharmaceuticals, Inc.CompletedAdvanced Solid TumorsUnited States
-
EndocyteCompletedPituitary TumorsUnited States
-
EndocyteCompletedHead and Neck Cancer | Bladder Cancer | Pancreas Cancer | Testicular Cancer | Recurrent or Metastatic Cancer
-
EndocyteCompletedOvarian Cancer | Endometrial CancerUnited States
-
EndocyteCompletedMetastatic Renal Cell CarcinomaUnited States
-
EndocyteCompletedRecurrent Endometrial Carcinoma | Ovarian Carcinoma
-
EndocyteCompletedOvarian Cancer | Healthy VolunteersUnited States
-
EndocyteCompletedMetastatic Renal Cell CarcinomaUnited States
-
EndocyteCompletedOvary CancerCanada, United States
-
EndocyteCompletedSolid Tumors | Non Small Cell Lung CarcinomaUnited States
-
NovartisCompleted
-
NovartisCompleted
-
NovartisCompleted
-
TCRCure Biopharma Ltd.Fudan UniversityRecruiting
-
EndocyteTerminated
-
EndocyteCompleted
-
EndocyteCompleted
-
EndocyteCompleted